JAYASRI DASAR RAJU
Allopathic & Osteopathic Physicians|Family Medicine NAPERVILLE, IL NPI 1679748552
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine IL ABBVIE INC. All categories
General Payments — all program years on this page
$4,177.36
- Category: General Payments
- Program years: PY2018–2024
- Record count: 244
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $193.26 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $193.26 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $53.82 | 2 |
| PFIZER INC. | $39.13 | 2 |
| Janssen Pharmaceuticals, Inc | $21.73 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.75 | 1 |
| Acerta Pharma LLC | $19.50 | 1 |
| Lilly USA, LLC | $19.23 | 1 |
| CooperSurgical, Inc. | $19.10 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078010724 | Janssen Pharmaceuticals, Inc | $21.73 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103602396 | ABBVIE INC. | $32.86 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103602398 | ABBVIE INC. | $20.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104470288 | AstraZeneca Pharmaceuticals LP | $19.50 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118107973 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130881864 | PFIZER INC. | $21.41 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131913077 | PFIZER INC. | $17.72 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135032994 | Lilly USA, LLC | $19.23 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150789657 | CooperSurgical, Inc. | $19.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.